Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 25, 2026Last filing: 10-Q on Oct 21, 2026Score 13/3018% above fair value

$227.97−4.26 (-1.83%)

Close on Nov 2, 2026Market cap $160.26BP/E 37.3Yield –

Danaher HemoCue (Point-of-Care POC Hematology Testing) by Year

Name: Danaher HemoCue (Point-of-Care POC Hematology Testing) by Year (DHR)
Creator: Danaher

HemoCue (Point-of-Care POC Hematology Testing) — MAUDE Adverse Event Reports

Quarterly Annual Monthly

Danaher HemoCue (Point-of-Care POC Hematology Testing): 0 in FY2025, down 100.0% from a year earlier. That is the lowest of the 10 years on record here.

Latest, FY2025

Period ended Dec 31, 2025

Change on a year earlier

-100.0%

1 in FY2024

History

10 years

Since FY2015

Sources

U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE)

Where the FY2025 figure comes from

Source: U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗

Reported in U.S. FDA openFDA MAUDE Adverse Event API.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	HemoCue (Point-of-Care POC Hematology Testing) — MAUDE Adverse Event Reports	Year on year	Source
FY2025	Dec 31, 2025	0	-100.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2024	Dec 31, 2024	1	–	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2023	Dec 31, 2023	0	–	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2022	Dec 31, 2022	0	–	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2021	Dec 31, 2021	0	–	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2020	Dec 31, 2020	0	-100.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2019	Dec 31, 2019	10	+150.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2018	Dec 31, 2018	4	-55.6%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2017	Dec 31, 2017	9	–	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2015	Dec 31, 2015	19	–	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗

Cite this data

StockData. (2026). Danaher HemoCue (Point-of-Care POC Hematology Testing), annual FY2015–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-fda-maude-hemocue

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.